Key Appointments in Biomedical Engineering

We are delighted to announce that as a key part of the strategic plan of the Department of Engineering Science and the University of Oxford, two new Professors of Biomedical Engineering have been elected. Alison Noble and Constantin Coussios have each been appointed as Professors of Biomedical Engineering to develop research and teaching in biomedical engineering. They will be based at the Department’s Institute of Biomedical Engineering (IBME) in Headington, Oxford.

Professor Alison Noble, FREngProfessor Alison Noble, FREng has been elected Professor of Biomedical Engineering in association with a fellowship at St Hilda’s College. She has been appointed to lead new cross-divisional activities in cardiovascular engineering and imaging.

Professor Noble joined the faculty at the University of Oxford in 1995, having previously worked at the GE Corporate Research and Development Centre, Niskayuna NY, USA as a research scientist from 1989-1994. She has been a Professor of Engineering Science at the University of Oxford since 2002 and was elected a Fellow of the Royal Academy of Engineering in 2008.

Professor Noble currently heads an internationally recognised research programme in biomedical image analysis based at the Department’s Institute of Biomedical Engineering (IBME) in Headington, Oxford. This involves close collaboration with clinical colleagues in cardiovascular medicine, women’s health and oncology. She is Director of the RCUK (Research Councils UK) Centre for Doctoral Training in Healthcare Innovation also based at the IBME.

Professor Noble is the first woman to be elected to a Statutory Professorship in Engineering at the University of Oxford.

Professor Constantin CoussiosDr Constantin Coussios has been elected to the Professorship of Biomedical Engineering in association with a fellowship at Magdalen College. His role will be to lead cross-divisional endeavours in the area of drug delivery, focussing particularly on the use of devices and engineering techniques to enable targeted drug delivery and enhance drug activity.

Following post-doctoral appointments at the University of Cincinnati and at Boston University under the F.V. Hunt Fellowship of the Acoustical Society of America, Professor Coussios first joined the University of Oxford in 2004 as the Powderject Fixed-Term Lecturer in Biomedical Engineering. He was subsequently appointed to the Bellhouse Foundation University Lectureship in Biomedical Engineering in 2006.

He founded and heads the Biomedical Ultrasonics and Biotherapy Laboratory based at the Oxford Institute of Biomedical Engineering, which explores therapeutic applications of ultrasound to non-invasive surgery and drug delivery in collaboration with clinical colleagues at the HIFU unit, the Nuffield Department of Surgical Sciences and the new Cancer Centre.

In 2007, he received the Institute of Acoustics Young Investigator Award for Innovation in Acoustical Engineering, and was recognised with a Challenging Engineering award by the UK’s Engineering and Physical Sciences Research Council. He received the title of Reader by the University of Oxford in 2008 and was elected as the youngest ever Fellow of the Acoustical Society of America in 2010. He is also an academic founder and technical director of the Oxford University spin-out OrganOx, which is developing a novel clinical normothermic organ perfusion device for organ preservation prior to transplantation and targeted drug delivery.